Soluble guanylate stimulators work independent of NO and thus may be effective molecules to activate the NO-sGC-cGMP signaling pathway in a state of low NO which is seen in heart failure due to oxidative stress [16]. Figure 2 below depicts the mechanism of action of the soluble guanylate cyclase stimulator, vericiguat. Here, SGCB is linked to heart failure.